Sector: healthGLP
Conviction from: NASDAQS&P
Tradable on: Bitget →
52-week range: 312.38483.99
Amgen is a biotechnology company that discovers, develops, and markets human therapeutics for oncology, inflammation, cardiovascular, and other serious diseases.
4 tracked filer(s) hold this · 0 opened, 2 added, 2 trimmed in 30-SEP-2026
Aggregate 13FScore 58 — mean of 4 scored holder(s) · buyers (new/add) avg 48. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Ancora | 42 | Added +1% | 34,865 | $14,695,786 | 0.3% |
| Bridgewater | 55 | Added +424% | 114,655 | $48,328,229 | 0.2% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -40% | 130,325 | $54,933,291 | 0.1% |
| Steve Cohen / Point72 | 75 | Trimmed -17% | 21,900 | $9,231,069 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
2 disclosed trade(s) by 2 filer(s).
12 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-08-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $100,001 - $250,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| Report | Date | Stance |
|---|
| #92 — Market Memo: Talk to Me, Goose | 2025-04-13 | SHORT |
| #90 — Market Memo: Insuring Against Insanity | 2025-03-31 | SHORT |